Hazard ratio for recurrent relapses - A modern efficacy measure for clinical trials in relapsing multiple sclerosis

被引：0
|
作者：
Bogumil, T
Jakobs, P
Salazar-Grueso, E
Fleming, T
机构：
来源：
NEUROLOGY | 2005年 / 64卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A324 / A324
页数：1
相关论文
共 50 条
  • [1] Pragmatic clinical trials for treating relapsing multiple sclerosis
    Mowry, Ellen M.
    Ontaneda, Daniel
    Evangelou, Nikos
    Newsome, Scott D.
    LANCET NEUROLOGY, 2019, 18 (12): : 1075 - 1075
  • [2] Limitations of the Hazard Ratio as a Summary Measure in Cancer Clinical Trials
    Dao, Quynh-Lan
    Phung, Quan
    Liu, Michael A.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : E86 - E87
  • [3] Correlates and trajectories of relapses in relapsing–remitting multiple sclerosis
    Carolyn A. Young
    David J. Rog
    Basil Sharrack
    Radu Tanasescu
    Seema Kalra
    Timothy Harrower
    Alan Tennant
    Roger J. Mills
    Neurological Sciences, 2024, 45 : 2181 - 2189
  • [4] Assessing relapses in treatment trials of relapsing and remitting multiple sclerosis: can we do better?
    Liu, C
    Blumhardt, LD
    MULTIPLE SCLEROSIS, 1999, 5 (01): : 22 - 28
  • [5] Clinical trials in multiple sclerosis - The importance of the outcome measure
    Zajicek, J
    Thompson, A
    Hobart, J
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (08): : 1215 - 1215
  • [6] Response to "Limitations of the Hazard Ratio as a Summary Measure in Cancer Clinical Trials"
    Zhao, Hongyun
    Li, Jibin
    Zhang, Zhonghan
    Zhang, Li
    Zhou, Xianfeng
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : E87 - E88
  • [7] Hazard ratio in clinical trials
    Spruance, SL
    Reid, JE
    Grace, M
    Samore, M
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (08) : 2787 - 2792
  • [8] Rapidity of onset of ocrelizumab clinical efficacy in relapsing multiple sclerosis
    Hauser, Stephen L.
    Kappos, Ludwig
    Bar-Or, Amit
    Hartung, Hans-Peter
    Belachew, Shibeshih
    Han, Jian
    Julian, Laura
    Napieralski, Julie
    Wolinsky, Jerry
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP13 - NP14
  • [9] Rapidity of Onset of Ocrelizumab Clinical Efficacy in Relapsing Multiple Sclerosis
    Hauser, Stephen
    Kappos, Ludwig
    Bar-Or, Amit
    Hartung, Hans-Peter
    Belachew, Shibesh H.
    Han, Jian
    Julian, Laura
    Napieralski, Julie
    Wolinsky, Jerry
    NEUROLOGY, 2017, 88
  • [10] Correlates and trajectories of relapses in relapsing-remitting multiple sclerosis
    Young, Carolyn A.
    Rog, David J.
    Sharrack, Basil
    Tanasescu, Radu
    Kalra, Seema
    Harrower, Timothy
    Tennant, Alan
    Mills, Roger J.
    NEUROLOGICAL SCIENCES, 2024, 45 (05) : 2181 - 2189
12345